Production (Stage)
Century Therapeutics, Inc.
IPSC
$0.583
$0.00761.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 372.82% | 8.44% | 4.57% | 6.26% | 10.24% |
| Total Depreciation and Amortization | -0.15% | -6.59% | -1.55% | 7.05% | 10.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.25% | -38.84% | -60.18% | -104.49% | 18.80% |
| Change in Net Operating Assets | -1,184.68% | 129.92% | -114.91% | -82.56% | -127.40% |
| Cash from Operations | -14.46% | 7.65% | -107.58% | -41.98% | -3.52% |
| Capital Expenditure | 11.87% | 84.29% | 124.62% | 94.11% | 89.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.14% | 57.18% | 412.88% | -309.09% | -66.75% |
| Cash from Investing | 142.01% | 64.52% | 829.55% | -585.57% | -63.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.21% | -- | 24,798.33% | -16.13% | -18.30% |
| Repurchase of Common Stock | -- | -69.10% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.34% | -69.10% | -9.00% | 660.41% | 3,961.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,183.79% | 172.42% | 221.99% | 79.91% | -119.95% |